Desk›Healthcare› Fortis Healthcare Ltd
Fortis Healthcare Ltd
BSE 532843 · NSE FORTIS · ISIN INE061F01013 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹916.20
-0.20%
BSE close, 28 August 2026
₹69,169.27 cr
75.5 cr shares · Mid cap
₹47,606.85 cr
as published
305.4× · 7.62×
EPS ₹3.00 · BV ₹120.24
1,792.50 / 230.34
₹ cr, as filed
36
8 selected · 22%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -17.1% |
|---|---|
| Against 52-week low | +19.4% |
| Day change | -0.20% |
| Size band | Mid cap |
| Index membership | NIFTY 500, NIFTY INFRASTRUCTURE |
Valuation as published by BSE
| Earnings per share | ₹3.00 |
|---|---|
| Price / earnings | 305.40× |
| Price / book | 7.62× |
| Book value — derived, price ÷ P/B | ₹120.24 |
| Return on equity | 2.49% |
| Operating margin | 27.82% |
| Net margin | 9.76% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 2.50%
- ROE as published
- 2.49%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 489.45 | 47.78 | 0.63 | 27.82% | 9.76% |
| Mar-26 · Q | 460.73 | 24.98 | 0.33 | 24.91% | 5.42% |
| FY25-26 | 1,792.50 | 230.34 | 3.05 | 33.10% | 12.85% |
Quarter on quarter
- Revenue, quarter on quarter
- +6.2%
- Net profit, quarter on quarter
- +91.3%
- Operating margin, quarter on quarter
- +291 bps
Disclosure profile 36 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Concall Transcript | 2 |
| Press Release | 2 |
| Board Outcome | 1 |
| Change in Management | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 8 |
| Procedural | |
| Analyst / Investor Meet | 11 |
| General | 9 |
| AGM / EGM | 3 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 28 |
| Total | 36 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 98 trading days
36 filings · 8 selected · busiest 2026-08-06
Filing rhythm · the twelve most recent
2026-09-112026-10-13
SelectedProcedural
Filings
36 in the window · 18 earlier on record
-
13 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Relevant Disclosure is Attached.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
12 October 2026 ·
To Invest In Special Purpose Vehicle (SPV) Under A Captive Solar Power Generation Project In The State Of Haryana
The relevant disclosure is attached.
Company Update / General View filing →
-
12 October 2026 ·
Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017)
The relevant disclosure is attached.
Others / Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) View filing →
-
29 September 2026 ·
Announcement / Press Release Filed By IHH Healthcare Berhad ('IHH')
The relevant disclosure is attached.
Company Update / General View filing →
-
25 September 2026 ·
Closure of Trading Window
The relevant disclosureis attached.
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 September 2026 ·
Update On Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company, Limited Before The Tokyo District Court In Japan
The relevant disclosure is attached
Company Update / General View filing →
-
16 September 2026 ·
Press Release / Media Release
The relevant disclosure is attached.
Company Update / Press Release / Media Release View filing →
-
16 September 2026 ·
Intimation For Signing The Definitive Agreements By Fortis Hospotel Limited (Wholly Owned Subsidiary Of The Company) To Provide Healthcare Services To A 400+ Bedded Super Specialty Hospital In Ashok Vihar, New Delhi
The relevant disclosure is attached.
Company Update / General View filing →
-
16 September 2026 ·
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 About Filing Of Special Leave Petition ('SLP') Before The Hon'Ble Supreme Court Of India
The relevant disclosure is attached.
Company Update / General View filing →
-
15 September 2026 ·
Analyst / Investor Meet - Intimation
The Relevant Disclosure is Attached.
Company Update / Analyst / Investor Meet View filing →
-
15 September 2026 ·
Analyst / Investor Meet - Intimation
The Relevant Disclosure is Attached.
Company Update / Analyst / Investor Meet View filing →
-
11 September 2026 ·
Update On Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company, Limited Before The Tokyo District Court In Japan.
The relevant disclosure is attached.
Company Update / General View filing →
-
10 September 2026 ·
Earnings Call Transcript
The relevant disclosure is attached.
Company Update / Earnings Call Transcript View filing →
-
9 September 2026 ·
Analyst / Investor Meet - Intimation
The revised Intimation is attached.
Company Update / Analyst / Investor Meet View filing →
-
9 September 2026 ·
Analyst / Investor Meet - Intimation
The revised Intimation is attached.
Company Update / Analyst / Investor Meet View filing →
-
9 September 2026 ·
Analyst / Investor Meet - Intimation
The relevant disclosure is attached
Company Update / Analyst / Investor Meet View filing →
-
9 September 2026 ·
Analyst / Investor Meet - Intimation
The relevant disclosre is attached.
Company Update / Analyst / Investor Meet View filing →
-
4 September 2026 ·
Analyst / Investor Meet - Outcome
The Relevant disclosure is attached.
Company Update / Analyst / Investor Meet View filing →
-
1 September 2026 ·
Analyst / Investor Meet - Intimation
The Relevant Disclosure is Attached.
Company Update / Analyst / Investor Meet View filing →
-
1 September 2026 ·
Regarding Order Passed By The Hon'Ble Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company, Limited Inter Alia The Company. Detailed Disclosure Is Attached.
Relevant disclosure is attached.
Company Update / General View filing →
-
24 August 2026 ·
-
11 August 2026 ·
Earnings Call Transcript
Relevant disclosure attached
Company Update / Earnings Call Transcript View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Relevant disclosure attached
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Summary Of The Proceedings Of The 30Th Annual General Meeting.
The relevant disclosure is attached.
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of 30th Annual General Meeting
AGM/EGM / AGM View filing →
-
7 August 2026 ·
Newspaper Publication
Relevant disclosure is attached
Company Update / Newspaper Publication View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Outcome
Relevant disclosure is attached
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026 ·
Investor Presentation
The relevant disclosure is attached.
Company Update / Investor Presentation View filing →
-
6 August 2026 ·
Press Release / Media Release
The relevant disclosure is attached.
Company Update / Press Release / Media Release View filing →
-
6 August 2026 ·
-
6 August 2026 ·
Financial Results Quarter Ended June 30, 2026
The Relevant disclosure is attached
Result / Financial Results View filing →
-
6 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
The relevant disclosure is attached
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The relevant disclosure is attached.
Company Update / General View filing →
-
31 July 2026 ·
Analyst / Investor Meet - Intimation
Relevant disclosure is attached
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Analyst / Investor Meet - Intimation
Relevant Disclosure is attached
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026.
Fortis Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Un-audited financial ....
Board Meeting / Board Meeting View filing →
RSS feed for Fortis Healthcare Ltd · the 50 most recent filings